Raquel Ciérvide (@raquel_ciervide) 's Twitter Profile
Raquel Ciérvide

@raquel_ciervide

Radiation Oncologist. HM Hospitales. Madrid. Breast&Lung Cancer, Brain&Spine,Oligomets.
Great things never come from comfort zones

ID: 1139276515781304320

calendar_today13-06-2019 21:01:02

1,1K Tweet

1,1K Takipçi

1,1K Takip Edilen

PDBrown (@pdbrownonc) 's Twitter Profile Photo

Randomized Trial Vestibular Schwannoma SRS vs fractionated SRS · No diff Hearing preserv, Tumor Control, Toxicity sciencedirect.com/science/articl…

Randomized Trial Vestibular Schwannoma SRS vs fractionated SRS
· No diff Hearing preserv, Tumor Control, Toxicity
sciencedirect.com/science/articl…
Angel Montero Luis (@monthy_a) 's Twitter Profile Photo

📢Our last paper providing practical tips&tricks to support low-dose radiotherapy for non-malignant disorders: ✅Who is LDRT for? ✅Why implement LDRT? ✅How does LDRT work? ✅Is LDRT safe? ✅What resources do I need? RadioterapiaHM HM HOSPITALES rdcu.be/ejBzx

📢Our last paper providing practical tips&tricks to support low-dose radiotherapy for non-malignant disorders:
✅Who is LDRT for?
✅Why implement LDRT?
✅How does LDRT work?
✅Is LDRT safe?
✅What resources do I need?
 <a href="/RadioterapiaHM/">RadioterapiaHM</a> <a href="/HMHOSPITALES/">HM HOSPITALES</a> 
rdcu.be/ejBzx
PDBrown (@pdbrownonc) 's Twitter Profile Photo

Spine SRS for Intradural Tumors · 207 tumors · Median dose SRS 14 Gy, fSRS 21/3 · 90% LC 10 yr · MVA: Absence NF1, Single frac SRS(despite larger tumors) pred ↑↑LC journals.lww.com/neurosurgery/a…

Spine SRS for Intradural Tumors
· 207 tumors
· Median dose SRS 14 Gy, fSRS 21/3
· 90% LC 10 yr
· MVA: Absence NF1, Single frac SRS(despite larger tumors) pred ↑↑LC
journals.lww.com/neurosurgery/a…
José Enrique (@jealesm) 's Twitter Profile Photo

¿Ni doble ni simple mastectomía en cáncer BRCA? Long-Term Oncologic Outcome of BCT in Patients With Breast Cancer With BRCA Variants jamanetwork.com/journals/jaman…

PDBrown (@pdbrownonc) 's Twitter Profile Photo

🚨 Randomized Trial: Significantly less symptom burden with SRS compared to HA-WBRT. SRS Standard of Care for 5-20 brain mets 🚨🚨🚨

🚨 Randomized Trial: Significantly less symptom burden with SRS compared to HA-WBRT. 
SRS Standard of Care for 5-20 brain mets 🚨🚨🚨
Icro Meattini (@icro_meattini) 's Twitter Profile Photo

ASCENT-04 - sacituzumab govitecan plus pembrolizumab as a new standard for #BreastCancer with previously untreated PDL1+ TNBC #ASCO25 Sara Tolaney OncoAlert #OncoAlert

ASCENT-04 - sacituzumab govitecan plus pembrolizumab as a new standard for #BreastCancer with previously untreated PDL1+ TNBC #ASCO25 

<a href="/stolaney1/">Sara Tolaney</a> <a href="/OncoAlert/">OncoAlert</a> #OncoAlert
Raquel Ciérvide (@raquel_ciervide) 's Twitter Profile Photo

Enhorabuena a los compañeros de Castilla y León y en especial a Dr. Luis A. Pérez-Romasanta por la extraordinaria 4° reunion de #SORCYL. Ha sido un placer compartir con vosotros!

Enhorabuena a los compañeros de Castilla y León y en especial a <a href="/LuisAlberto3P/">Dr. Luis A. Pérez-Romasanta</a> por la extraordinaria 4° reunion de #SORCYL. Ha sido un placer compartir con vosotros!
Joseph (Joe) Sia (@_joesia) 's Twitter Profile Photo

🧠💥 Pre-op SRS for brain mets is gaining traction. But must we resect 1–3 days after? 🤔 We ran a small feasibility trial. Biological rationale: keeping the irradiated tumor in situ longer may allow immune responses within the tumor to develop🕒 link.springer.com/article/10.100…

Angel Montero Luis (@monthy_a) 's Twitter Profile Photo

📢The experience from RadioterapiaHM is just out!! 🎯Clinician- And Patient-Reported Outcomes Of Stereotactic Ablative Radiotherapy For High-Risk Prostate Cancer #radonc #pcsm #SABR practicalradonc.org/article/S1879-…

Irish Research Radiation Oncology Group (@irrogtrials) 's Twitter Profile Photo

1st pt in Ireland randomised on the oligomet breast cancer TAORMINA trial in St. Luke's Hospital. Well done to all involved. Thsi trial offers pts the chance to have high dose radiation to discrete areas of cancer spread on this important trial! #breastoncology #clinicaltrials

1st pt in Ireland randomised on the oligomet breast cancer TAORMINA trial in St. Luke's Hospital.

Well done to all involved.

Thsi trial offers pts the chance to have high dose radiation to discrete areas of cancer spread on this important trial!

#breastoncology #clinicaltrials
7º Congreso Español de la Mama (@congresomama) 's Twitter Profile Photo

🎙️ Os presentamos a los participantes de la segunda mesa del 7º Congreso Español de la Mama 🗓️Viernes 17 octubre 2025 📢 ¡No te lo pierdas! ✅ Inscríbete congresodelamama.org/inscripcion/ 📝 Envía tu comunicación congresodelamama.org/comunicaciones… #7CEMA #patologiamamaria #cancerdemama

🎙️ Os presentamos a los participantes de la segunda mesa del <a href="/congresomama/">7º Congreso Español de la Mama</a>

🗓️Viernes 17 octubre 2025

📢 ¡No te lo pierdas!
✅ Inscríbete congresodelamama.org/inscripcion/
📝 Envía tu comunicación congresodelamama.org/comunicaciones…

#7CEMA #patologiamamaria #cancerdemama
Jonas Willmann, MD (@jonas_willmann) 's Twitter Profile Photo

🫁 Intrathoracic relapse after PACIFIC-regimen for LA-NSCLC remains a major therapeutic challenge. 🧪 In the AUSTRAL trial, led by Matthias Guckenberger & Andrea R. Filippi, we target this unmet need by combining RT (reRT and/or metastatis-directed SBRT) + durvalumab + ceralasertib

🫁 Intrathoracic relapse after PACIFIC-regimen for LA-NSCLC remains a major therapeutic challenge.

🧪 In the AUSTRAL trial, led by <a href="/Mat_Guc/">Matthias Guckenberger</a>  &amp; <a href="/AndrearicFili/">Andrea R. Filippi</a>, we target this unmet need by combining  RT (reRT and/or metastatis-directed SBRT)  + durvalumab +  ceralasertib
Joshua D. Palmer, MD (@joshuapalmermd) 's Twitter Profile Photo

Remarkable response to Boswellia after necrosis due to high dose brain SRS. In case you didn’t know I am a strong advocate for Boswellia we should all be using this!!! advancesradonc.org/article/S2452-…